Skip to main content
. 2020 May 18;28(9):1178–1186. doi: 10.1038/s41431-020-0640-x

Table 2.

Participants’ choices of secondary findings.

Category 1:
Medically actionable diseases
Category 2:
Common disease SNPs
Category 3:
Rare Mendelian disorders
Category 4:
Early-onset neurological conditions
Category 5:
Carrier status
Yes 30 (96.8%) 24 (77.4%) 21 (67.7%) 20 (64.5%) 23 (74.2%)
No 1 (3.2%) 6 (19.4%) 6 (19.4%) 7 (22.6%) 5 (16.1%)
Unsure 0 (0%) 1 (3.2%) 4 (12.9%) 4 (12.9%) 3 (9.7%)